Literature DB >> 32870978

COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes.

Sergio Alejandro Gómez-Ochoa, Oscar H Franco, Lyda Z Rojas, Peter Francis Raguindin, Zayne Milena Roa-Díaz, Beatrice Minder Wyssmann, Sandra Lucrecia Romero Guevara, Luis Eduardo Echeverría, Marija Glisic, Taulant Muka.   

Abstract

Health-care workers (HCWs) are at the frontline of response to coronavirus disease 2019 (COVID-19), being at a higher risk of acquiring the disease and, subsequently, exposing patients and others. Searches of 8 bibliographic databases were performed to systematically review the evidence on the prevalence, risk factors, clinical characteristics, and prognosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among HCWs. A total of 97 studies (all published in 2020) met the inclusion criteria. The estimated prevalence of SARS-CoV-2 infection from HCWs' samples, using reverse transcription-polymerase chain reaction and the presence of antibodies, was 11% (95% confidence interval (CI): 7, 15) and 7% (95% CI: 4, 11), respectively. The most frequently affected personnel were nurses (48%, 95% CI: 41, 56), whereas most of the COVID-19-positive medical personnel were working in hospital nonemergency wards during screening (43%, 95% CI: 28, 59). Anosmia, fever, and myalgia were the only symptoms associated with HCW SARS-CoV-2 positivity. Among HCWs positive for COVID-19 by reverse transcription-polymerase chain reaction, 40% (95% CI: 17, 65) were asymptomatic at time of diagnosis. Finally, severe clinical complications developed in 5% (95% CI: 3, 8) of the COVID-19-positive HCWs, and 0.5% (95% CI: 0.02, 1.3) died. Health-care workers suffer a significant burden from COVID-19, with those working in hospital nonemergency wards and nurses being the most commonly infected personnel.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  2019-nCoV; COVID-19; SARS-CoV-2; health-care workers; medical workers

Year:  2021        PMID: 32870978      PMCID: PMC7499478          DOI: 10.1093/aje/kwaa191

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  166 in total

1.  Doctors Spreading SARS-CoV-2 Infection to Their Patients and Health Workers. What is the Likelihood of This Scenario?

Authors:  Effrosyni D Palla; Jiannis Hajiioannou; Vasileios A Lachanas; Nikos Kalogritsas; Fani Saini; Despoina Beka; Charikleia Maiou; Charalampos Skoulakis
Journal:  Maedica (Bucur)       Date:  2021-09

2.  A Simplified Comorbidity Evaluation Predicting Clinical Outcomes Among Patients With Coronavirus Disease 2019.

Authors:  Jessica J Kirby; Sajid Shaikh; David P Bryant; Amy F Ho; James P d'Etienne; Chet D Schrader; Hao Wang
Journal:  J Clin Med Res       Date:  2021-04-27

3.  Ethical factors determining ECMO allocation during the COVID-19 pandemic.

Authors:  Bernadine Dao; Julian Savulescu; Jacky Y Suen; John F Fraser; Dominic J C Wilkinson
Journal:  BMC Med Ethics       Date:  2021-06-01       Impact factor: 2.652

4.  Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.

Authors:  Shohei Yamamoto; Akihito Tanaka; Yusuke Oshiro; Masamichi Ishii; Hironori Ishiwari; Maki Konishi; Kouki Matsuda; Mitsuru Ozeki; Kengo Miyo; Kenji Maeda; Tetsuya Mizoue; Wataru Sugiura; Hiroaki Mitsuya; Haruhito Sugiyama; Norio Ohmagari
Journal:  J Infect       Date:  2021-05-25       Impact factor: 6.072

5.  Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.

Authors:  Sherief Musa; Shereen Abdel Alem; Khaled Amer; Tarek Elnagdy; Wael A Hassan; Mohamed A Ali; Yasmine Gaber; Hedy A Badary; Omnia Tantawi; Reham Abdelmoniem; Amr Radwan; Hanaa Yousof; Shereen Shawky; Hala Talaat; Rabab Fouad; Abdel Meguid Kassem
Journal:  J Infect Public Health       Date:  2021-06-10       Impact factor: 3.718

6.  COVID-19 Vaccination: Status and Willingness to Be Vaccinated among Employees in Health and Welfare Care in Germany.

Authors:  Agnessa Kozak; Albert Nienhaus
Journal:  Int J Environ Res Public Health       Date:  2021-06-22       Impact factor: 3.390

7.  Predictors of violence against health professionals during the COVID-19 pandemic in Brazil: A cross-sectional study.

Authors:  Mariá Romanio Bitencourt; Ana Carolina Jacinto Alarcão; Lincoln Luís Silva; Amanda de Carvalho Dutra; Nayara Malheiros Caruzzo; Igor Roszkowski; Marcos Rogério Bitencourt; Vlaudimir Dias Marques; Sandra Marisa Pelloso; Maria Dalva de Barros Carvalho
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

8.  Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy.

Authors:  Piero Poletti; Marcello Tirani; Danilo Cereda; Giorgio Guzzetta; Filippo Trentini; Valentina Marziano; Claudia Toso; Alessandra Piatti; Raffaella Piccarreta; Alessia Melegaro; Aida Andreassi; Maria Gramegna; Marco Ajelli; Stefano Merler
Journal:  JAMA Netw Open       Date:  2021-07-01

9.  COVID-19 cumulative incidence, asymptomatic infections, and fatality in Long Island, NY, January-August 2020: A cohort of World Trade Center responders.

Authors:  Olga Morozova; Sean A P Clouston; Jennifer Valentine; Alexander Newman; Melissa Carr; Benjamin J Luft
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240

10.  Seroprevalence of SARS-CoV-2 Antibodies in Symptomatic Individuals Is Higher than in Persons Who Are at Increased Risk Exposure: The Results of the Single-Center, Prospective, Cross-Sectional Study.

Authors:  Alexandr Zurochka; Maria Dobrinina; Vladimir Zurochka; Desheng Hu; Alexandr Solovyev; Liana Ryabova; Igor Kritsky; Roman Ibragimov; Alexey Sarapultsev
Journal:  Vaccines (Basel)       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.